Should a serum paracetamol (acetaminophen) level be obtained in every overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Should You Always Check a Paracetamol Level in Any Overdose?

Yes, you should routinely obtain a serum paracetamol level in all patients presenting with any overdose, even when they deny taking paracetamol. This is critical because paracetamol toxicity is initially asymptomatic, can cause severe hepatotoxicity and death if untreated, and has an effective antidote (N-acetylcysteine) that must be given within 8-10 hours for optimal outcomes 1.

Why Universal Testing is Essential

The evidence strongly supports universal paracetamol testing in overdose patients for several compelling reasons:

Paracetamol is ubiquitous and deadly: It's involved in approximately 6% of all poisonings but accounts for 56% of severe acute liver injury and acute liver failure cases 2. The window for effective treatment is narrow—N-acetylcysteine prevents severe hepatotoxicity when given within 8-10 hours, but severe hepatotoxicity rises to 26-53% when treatment is delayed beyond 10 hours 1.

Patient history is unreliable: A critical study of 307 consecutive overdose patients found that 13 patients who denied taking paracetamol actually had detectable blood concentrations 3. While these particular patients didn't require treatment, the study concluded that all patients alleging an overdose need paracetamol concentrations checked because achieving the <1% false negative rate that clinicians require would need a sample size of 20,000 patients 3.

Paracetamol is hidden in combination products: Many patients don't realize they've taken paracetamol because it's combined with other medications (opioids, cold remedies, etc.). This makes denial of paracetamol ingestion even less reliable 4.

The Clinical Algorithm

For ALL Overdose Patients:

  1. Obtain serum paracetamol level at 4 hours post-ingestion or immediately if presentation is >4 hours 1, 4

  2. Plot the level on the Rumack-Matthew nomogram (using the modified line that's 25% below the original, creating "possible" and "probable" risk zones) 1

  3. Initiate N-acetylcysteine for any patient in the possible or probable risk zones, ideally within 8-10 hours 1

Special Circumstances Requiring Immediate Testing:

  • Any patient with self-harm intent or suspected malicious administration → immediate ED referral regardless of reported dose 4
  • Patients with symptoms (repeated vomiting, right upper quadrant tenderness, mental status changes) → immediate ED referral 4
  • Unknown time of ingestion → immediate testing 1, 4
  • Delayed presentation (>24 hours) → cannot use nomogram; base treatment on clinical and laboratory findings 1

Important Caveats and Pitfalls

Timing matters critically: Levels drawn before 4 hours cannot be reliably interpreted using the nomogram 1. However, if a patient presents early, don't delay—send them to the ED to ensure the 4-hour level can be obtained and treatment initiated within the 8-10 hour window.

The nomogram doesn't apply to:

  • Repeated supratherapeutic ingestions (>4g/24 hours over multiple days) 1
  • Staggered overdoses (ingestions over >8 hours) 1
  • Extended-release formulations 1
  • Presentations >24 hours post-ingestion 1

For these scenarios, use clinical judgment, liver function tests (AST/ALT), and consider empiric N-acetylcysteine treatment 1.

High-risk patients need lower thresholds: Patients with chronic alcohol use, prolonged fasting, or taking enzyme-inducing drugs (like isoniazid) may develop toxicity at lower doses—consider the lower nomogram line for these patients 1, 4.

The Bottom Line on Universal Testing

While one study suggested that fully conscious, English-speaking patients with GCS 15 who deny paracetamol ingestion and haven't taken excessive alcohol might not need testing 5, this approach is not safe enough for clinical practice. The consequences of missing paracetamol toxicity (liver failure and death) far outweigh the minimal cost and inconvenience of universal testing 3. The 2006 evidence-based consensus guideline explicitly states that paracetamol testing is necessary because "the risks of delayed toxicity and lack of initial symptoms in those ingesting paracetamol suggests that continued routine testing is necessary" 5.

In practical terms: Order a paracetamol level on every overdose patient, regardless of their history. The test is inexpensive, the antidote is highly effective when given early, and the consequences of missing the diagnosis are catastrophic.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.